Search - tctmd.com

Displaying 141 - 160 of 271

Sort: Relevancy | Date

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

News Industry News

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

October 27, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Industry News

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

July 27, 2016

News Industry News

Vasorum Ltd. Receives FDA Approval for Celt ACD® Vascular Closure Device

July 21, 2016

News Daily News

Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor

Shelley Wood

July 20, 2016

News Daily News

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Michael O'Riordan

July 13, 2016

News Daily News

Study Supports Noninferiority of Dedicated Bifurcation Stent: But is That Good Enough for Adoption?

Todd Neale

July 08, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Features

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

Yael L. Maxwell

June 29, 2016

News Daily News

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Todd Neale

May 27, 2016

News Industry News

Medicure Files Application for New AGGRASTAT® Product Format

May 11, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

News Daily News

Northwestern Memorial Hospital and Star CV Surgeon Found Not Guilty in Myxo Ring Case

Shelley Wood

April 08, 2016

News Industry News

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™

March 28, 2016

News Daily News

Novel Oral Anticoagulant for VTE Prevention Misses Primary Endpoint in APEX

Todd Neale

March 24, 2016

News Industry News

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

March 21, 2016

News Industry News

Aralez resubmits to FDA New Drug Application for YOSPRALA

March 15, 2016

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

Advertisement

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Mercator MedSystems Announces First Patients Enrolled In U.S. Below The Knee (BTK) Clinical Trial In North Carolina And Texas

Vasorum Ltd. Receives FDA Approval for Celt ACD® Vascular Closure Device

Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor

AstraZeneca Strives to Block Generic Crestor as Observers Call Foul

Study Supports Noninferiority of Dedicated Bifurcation Stent: But is That Good Enough for Adoption?

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Medicure Files Application for New AGGRASTAT® Product Format

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

Northwestern Memorial Hospital and Star CV Surgeon Found Not Guilty in Myxo Ring Case

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™

Novel Oral Anticoagulant for VTE Prevention Misses Primary Endpoint in APEX

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

Aralez resubmits to FDA New Drug Application for YOSPRALA

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content